35761804|t|Ketamine administration ameliorates anesthesia and surgery-induced cognitive dysfunction via activation of TRPV4 channel opening.
35761804|a|Perioperative neurocognitive disorder (PND) is a common complication associated with anesthesia and surgery in the elderly. The dysfunction of transient receptor potential vanilloid 4 (TRPV4) has been associated with a number of diseases, including Alzheimer's disease. Given that ketamine can reportedly improve PNDs, the present study sought to determine whether ketamine-induced PND alleviation was mediated by activation of TRPV4 channel opening. A total of 120, 20-month-old male C57BL/6 mice were randomly divided into five groups: Vehicle, PND (tibial fracture surgery), PND + ketamine (Ket), PND + Ket + HC-067047 (HC), and PND + HC groups. Ketamine (0.5 mg/kg) was administered intraperitoneally once a day for 3 days after surgery and HC-067047 (1 micromol/2 microl), an antagonist of TRPV4, was administered via the left lateral ventricle 30 min before ketamine treatment. Superoxide dismutase (SOD), malondialdehyde (MDA), lipid peroxidation (LPO), IL-1beta, IL-6, adenosine monophosphate-activated protein kinase (AMPK), NF-kappaB, TNF-alpha and IFN-beta levels were determined 3 days after surgery. At 28 days after surgery, fear conditioning and novel object recognition were assessed, and Abeta1-42 levels were measured and ionized calcium binding adaptor molecule 1 (Iba1) staining was conducted on day 31 after surgery. The results revealed that ketamine administration upregulated total SOD activity, downregulated MDA and LPO content, mitigated phosphorylated (p)-NF-kappaB, TNF-alpha mRNA and IFN-beta mRNA expression in the hippocampus, and promoted p-AMPK 3 days after surgery. Furthermore, it was found that ketamine increased both context- and tone-dependent fear conditioning, and the time spent exploring a novel object, and reduced Abeta peptide levels and microglial activation 30 days after surgery. Notably, these changes could be reversed by HC-067047 to a certain extent. In conclusion, ketamine improved PND in aged mice after tibial fracture surgery and the potential mechanism may involve activation of the TRPV4/AMPK/NF-kappaB signaling pathway.
35761804	0	8	Ketamine	Chemical	MESH:D007649
35761804	67	88	cognitive dysfunction	Disease	MESH:D003072
35761804	107	112	TRPV4	Gene	63873
35761804	130	167	Perioperative neurocognitive disorder	Disease	MESH:D019965
35761804	169	172	PND	Disease	MESH:D019965
35761804	273	313	transient receptor potential vanilloid 4	Gene	63873
35761804	315	320	TRPV4	Gene	63873
35761804	379	398	Alzheimer's disease	Disease	MESH:D000544
35761804	411	419	ketamine	Chemical	MESH:D007649
35761804	443	447	PNDs	Disease	
35761804	495	503	ketamine	Chemical	MESH:D007649
35761804	512	515	PND	Disease	MESH:D019965
35761804	558	563	TRPV4	Gene	63873
35761804	615	622	C57BL/6	CellLine	CVCL:C0MU
35761804	623	627	mice	Species	10090
35761804	677	680	PND	Disease	MESH:D019965
35761804	682	697	tibial fracture	Disease	MESH:D013978
35761804	708	711	PND	Disease	MESH:D019965
35761804	714	722	ketamine	Chemical	MESH:D007649
35761804	724	727	Ket	Chemical	MESH:D007649
35761804	730	733	PND	Disease	MESH:D019965
35761804	736	739	Ket	Chemical	MESH:D007649
35761804	742	751	HC-067047	Chemical	MESH:C573308
35761804	753	755	HC	Chemical	MESH:D006854
35761804	762	765	PND	Disease	MESH:D019965
35761804	768	770	HC	Chemical	MESH:D006854
35761804	779	787	Ketamine	Chemical	MESH:D007649
35761804	875	884	HC-067047	Chemical	MESH:C573308
35761804	925	930	TRPV4	Gene	63873
35761804	994	1002	ketamine	Chemical	MESH:D007649
35761804	1042	1057	malondialdehyde	Chemical	MESH:D008315
35761804	1059	1062	MDA	Chemical	MESH:D008315
35761804	1065	1070	lipid	Chemical	MESH:D008055
35761804	1091	1099	IL-1beta	Gene	16176
35761804	1101	1105	IL-6	Gene	16193
35761804	1164	1173	NF-kappaB	Gene	18033
35761804	1175	1184	TNF-alpha	Gene	21926
35761804	1189	1197	IFN-beta	Gene	15977
35761804	1494	1502	ketamine	Chemical	MESH:D007649
35761804	1564	1567	MDA	Chemical	MESH:D008315
35761804	1614	1623	NF-kappaB	Gene	18033
35761804	1625	1634	TNF-alpha	Gene	21926
35761804	1644	1652	IFN-beta	Gene	15977
35761804	1762	1770	ketamine	Chemical	MESH:D007649
35761804	2004	2013	HC-067047	Chemical	MESH:C573308
35761804	2050	2058	ketamine	Chemical	MESH:D007649
35761804	2068	2071	PND	Disease	MESH:D019965
35761804	2080	2084	mice	Species	10090
35761804	2091	2106	tibial fracture	Disease	MESH:D013978
35761804	2173	2178	TRPV4	Gene	63873
35761804	2184	2193	NF-kappaB	Gene	18033
35761804	Negative_Correlation	MESH:D007649	15977
35761804	Negative_Correlation	MESH:D007649	MESH:D019965
35761804	Negative_Correlation	MESH:D007649	21926
35761804	Negative_Correlation	MESH:D007649	18033
35761804	Negative_Correlation	MESH:D007649	MESH:D008315
35761804	Negative_Correlation	MESH:C573308	63873
35761804	Positive_Correlation	MESH:D007649	63873
35761804	Association	MESH:D019965	63873
35761804	Negative_Correlation	MESH:C573308	MESH:D007649
35761804	Negative_Correlation	MESH:D007649	MESH:D003072
35761804	Association	MESH:D000544	63873
35761804	Association	MESH:D003072	63873
35761804	Negative_Correlation	MESH:C573308	MESH:D019965

